Upstate Active Clinical Trials
Study Title:A021502 - Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
What is the purpose of the study?This randomized phase III trial studies combination chemotherapy and Atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair.
Upstate Institutional Review Board (IRB) Number:1186549
Patient Age Group:Adults
Principal Investigator:Rahul Seth, DO
What is involved if I participate?
- Is transportation provided or reimbursed?
Where will the study take place?Upstate Cancer Center - All procedures
Oneida - All procedures
Oswego - All procedures
Who can I contact for more information?
Name: Nicole D Bunyea